Factor Bioscience Inc., a biotechnology company focused on developing mRNA and cell-engineering technologies, announced its participation in the American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting. The meeting will be held in from and Factor will deliver seven presentations, representing the company’s most expansive presentation of data to date.